Document Type : Original Research


Dept. of Anatomical Sciences and Pathology, Faculty of Medicine, Shahed University, Tehran, Iran


Background: Nasal inflammatory disorders such as chronic rhinosinusitis and nasal polyp are among the most prevalent complications with high socioeconomic costs. Vascular Endothelial Growth Factor (VEGF) plays a key role in angiogenesis and cell proliferation. In the present study the effect of VEGF on the development and prognosis of chronic rhinosinusitis and nasal polyp was investigated. Methods: This cross sectional study was performed on the nasal histological specimens of two groups of patients suffering from nasal polyp or chronic rhinosinusitis, and the expression of VEGF in the two groups was compared immunohistochemically. Based on the percentage of VEGF-positive cells the specimens were classified into four scores. Furthermore, the relations between the VEGF expression and some demographic characteristics were evaluated. Results: The VEGF immunohistochemistry findings indicated a significantly higher expression of VEGF in nasal polyp group compared to chronic rhinosinusitis without nasal polyp group. In terms of VEGF-expression scoring, in both groups most of the specimens were classified as score-2, namely indicating 10-50% of VEGF-positive epithelial cells. In both groups no significant relation between VEGF expression and age or sex of the patients could be seen. Conclusion: Local modulation of VEGF expression might be taken as a putative therapeutic strategy in management of sinunasal inflammatory disorders, especially nasal polyps. 


  1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS: European position paper on rhinosinusitis and nasal polyps 2012 A summary for otorhinolaryngologists. Rhinology. 2012;50:1–12. [PubMed]
  2. Kato A. Immunology of chronic rhinosinusitis. Alergology Int. 2015;64:121–30. [PMC free article] [PubMed]
  3. Anselmo-Lima WT, Sakano E, Tamashiro E, Araujo E, Ortiz E, Pinna F. Rhinosinusitis: evidence and experience. Braz J Orthorhinolaryngol. 2015;81(Sup 1):S1–S49. [PubMed]
  4. Cingi C, Demirbas D, Ural A. Nasal Polyposis: An Overview of Differential Diagnosis and Treatment. Recent Patents on Inflammation & Allergy Drug Discovery. 2011;5(3):241–252. [PubMed]
  5. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125(2):S103–S110. [PubMed]
  6. Akdis CA, Bacher C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European academy of allergy and clinical immunology and the American academy of alergy, asthma and immunology. J Allergy Clin Immunol. 2013;131:1479–90. [PMC free article] [PubMed]
  7. Van Bruaene N, Bacher C. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2011;11:8–11. [PubMed]
  8. Stjarne P, Blomgren K, Caye-Thomasen P, Salo S, Soderstrom T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2006;126:606–12. [PubMed]
  9. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116:189–193. [PubMed]
  10. Coste A, Brugel L, Maître B, Boussat S, Papon JF, Wingerstmann L, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J. 2000;15(2):367–72. [PubMed]
  11. Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000;22:657–64. [PubMed]
  12. Thanigaimani GD, Dhanaram B, Vijayalakshmi S. Histological analysis of Nasal Polyps in A Tertiary Hospital. J Dent Med Sci. 2015;14(6):18–20.
  13. Saikuniene J, Vaitkus S, Japertine LM, Ryskiene S. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. Medicine (Kaunas) 2008;44(4):257–65. [PubMed]
  14. Li C, Shi L, Yan Y, Gordon BR, Gordon WM, Wang DY. Gene Expression Signatures: A New Approach to Understanding the Pathophysiology of Chronic Rhinosinusitis. Current Allergy and Asthma Reports. 2013;13(2):209–17. [PubMed]
  15. Dietz de Loos DAE, Hopkins C, Fokkens WJ. Symptoms in Chronic Rhinosinusitis with and without Nasal Polyps. Laryngoscope. 2013;123:57–63. [PubMed]
  16. Lee H, Kim J. Constitutive expression of vascular endothelial cell growth factor (VEGF) gene family ligand and receptors on human upper and lower airway epithelial cells. Int Forum Allergy Rhinol. 2014;4(1):8–14. [PubMed]
  17. Hu KH, Lee FP, Cheng YJ, Huang HM. Vascular endothelial growth factor and children featuring nasal polyp. Int J Pediatr Otorhinolaryngol. 2007;71:23–8. [PubMed]
  18. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, et al. Heterozygous embryonic lethality by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442. [PubMed]
  19. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983–5. [PubMed]
  20. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, et al. Tumor vesicular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–8. [PMC free article] [PubMed]
  21. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362:841–4. [PubMed]
  22. Ho CL, Sheu LF, Li CY. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor and their receptors in stage IV Non-Hodgkin lymphoma. Appl Immunohistochem Mol Morphol. 2002;10:316–21. [PubMed]
  23. Rahimi N. VEGFR-1 andVEGFR-2: two non-identical twins with aunique physiognomy. Front Biosci. 2006;11:818–29. [PMC free article] [PubMed]
  24. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Di!erent signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269:26988–95. [PubMed]
  25. Fruth K, Zhu C, Schramek E, Angermair J, Kassem W, Haxel BR, et al. Vascular Endothelial Growth Factor Expression in Nasal Polyps of Aspirin-Intolerant Patients. Arch Otolaryngol Head Neck Surg. 2012;138(3):286–93. [PubMed]